Otros idiomas Clover Health Investments, Corp.

Acciones

CLOV

US18914F1030

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 26/04/2024			Varia. Cinco días.	Varia. 1 de enero.
0,68 ^USD	+1,49 %		+6,99 %	-28,58 %

19/03	Clover Health lanza un nuevo programa clínico en colaboración con Quartet Health para tratar las enfermedades mentales graves	CI
12/03	Transcript : Clover Health Investments, Corp., Q4 2023 Earnings Call, Mar 12, 2024

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Clover Health to Report First Quarter 2024 Financial Results on May 7, 2024	23/04
Clover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial Officer	22/04
Clover Health Investments, Corp. Announces the Appointment of Peter Kuipers as Chief Financial Officer	22/04
Clover Health Provides Notice Associated with Previously Disclosed Settlement of Shareholder Derivative Actions	04/04
Clover Health Launches New Clinical Program in Partnership with Quartet Health to Address Serious Mental Illness	19/03
Clover Health Launches New Clinical Program in Partnership with quarter Health to Address Serious Mental Illness	19/03
Clover Health Investments, Corp.(NasdaqGS:CLOV) dropped from S&P Health Care Services Select Industry Index	18/03
Clover Health's Remarkable Turnaround: A Deep Dive into 2023 Results and 2024 Outlook	14/03
Earnings Flash (CLOV) CLOVER HEALTH INVESTMENTS Reports Q4 Revenue $510.3M, vs. Street Est of $474M	12/03
Clover Health Investments, Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	12/03
Clover Health Investments, Corp. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	12/03
Clover Health Reports Fourth Quarter and Full Year 2023 Financial Results; Delivers Continued Momentum in Financial Performance and Provides Full-Year 2024 Guidance	12/03
Clover Health Investments, Corp. Reports Impairment of Goodwill and Other Intangible Assets for the Fourth Quarter Ended December 31, 2023	12/03
Clover Health Investments, Corp. Provides Revenue Guidance for the Full Year 2024	12/03
Industry Veteran Clay Thornton Joins Clover Health as CFO of Medicare Advantage	07/03
Clay Thornton Joins Clover Health as CFO of Medicare Advantage Division	07/03
North American Morning Briefing : Stock Futures -2-	27/02
Clover Health to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024	26/02
Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)	16/02
An In-Depth Analysis of Humana Inc. and the Shifting Dynamics in Medicare Advantage: Exploring the Potential for Clover Health	29/01

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Clover Health Investments, Corp.

Acciones

CLOV

US18914F1030

Otros idiomas

Filtros